"The groundwork of all happiness is health." - Leigh Hunt

A brand new drug to treat heart failure

About 6.2 million adults have heart failure, and the speed of hospitalizations for the condition has increased lately. Most individuals with heart failure need several medications to treat their symptoms. These include medications to assist lower blood pressure, remove excess fluids, and slow the guts rate to enhance the guts's pumping motion.

But recent guidelines issued in April 2022 by the American College of Cardiology and the American Heart Association add one other class of medicine to the treatment list: a gaggle of diabetes drugs referred to as sodium-glucose cotransporter-2 (SGLT- 2) called inhibitors.

What is heart failure?

Contrary to its name, heart failure doesn't mean that your heart has “failed,” but relatively that the guts doesn't pump properly. This mechanical problem may cause blood to back up within the veins resulting in the guts, causing the kidneys to retain fluid and body tissues to swell. The resulting fluid accumulation often affects the legs and ankles and may occur within the lungs.

A pumping problem can occur throughout the guts or simply on one side—left or right. Most cases are brought on by problems on the left side: the left ventricle (the guts's largest chamber) is just too weak or too stiff to pump normally.

Left-sided heart failure is assessed into one in all two important types depending on the guts's ejection fraction (EF) — the proportion of how much blood is pumped into the left ventricle with each contraction. Individuals with an EF of a minimum of 50% have heart failure with a preserved ejection fraction (HFpEF). People with an EF of lower than 40% have heart failure with a low ejection fraction (HFrEF). For individuals with an EF of 40% to 49%, the image is mixed.

Symptoms of each varieties of left-sided heart failure are similar. At first, chances are you'll just notice that you just're more drained or can't walk as fast as you used to. Other symptoms include difficulty respiration with exertion or while you lie flat; swelling within the legs, ankles, or each; And a persistent cough.

Treatment options

Treatment for each types includes avoiding high salt intake, keeping blood pressure under control, and being physically lively.

People with HFrEF have various medication options to enhance quality of life, reduce the danger of hospitalization, and offer longer life. These treatments traditionally include ACE inhibitors, angiotensin receptor blockers (ARBs), beta blockers, sacubitril/valsartan (Entresto), and diuretics (“water pills”).

In contrast, specific treatments for HFpEF have been limited to diuretics and a variety of medicines geared toward keeping blood pressure tolerably low.

According to Dr. Bhatt, SGLT-2 inhibitors fit into the treatment picture because they've several benefits. For example, they will treat each HFrEF and HFpEF in addition to advanced heart failure.

In diabetes, SGLT-2 inhibitors are used to forestall blood sugar from being reabsorbed by the kidneys, so excess is excreted through the urine. This same mechanism allows them to act as diuretics to combat the swelling brought on by heart failure. “The drugs also lower sodium levels, which helps lower high blood pressure,” says Dr. Bhatt. “They've been shown to help with weight loss and protect against kidney disease. And what's good for the kidneys is good for the heart.”

Growing evidence

The important SGLT-2s are canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance). The addition of SGLT-2 inhibitors to the rules was supported by several studies that support their use within the treatment of each varieties of heart failure in individuals with and without diabetes.

For example, a study within the October 14, 2021 issue New England Journal of Medicine found that folks with diabetes and HFpEF who took the SGLT-2 inhibitor empagliflozin had a lower risk of dying from heart disease or being hospitalized for heart failure than people treated with standard heart failure therapy. was An evaluation within the September 19, 2020 issue The Lancet SGLT-2 inhibitors end in a reduced risk of hospitalization and death from heart problems in individuals with HFrEF, with or without diabetes.

As with other heart failure medications, people must take SGLT-2 inhibitors regularly. “Once you stop taking them, they lose their benefit,” says Dr. Bhatt. Possible unwanted side effects include genital fungal infections. If you've heart failure or are in danger for it, seek advice from your doctor about whether this class of medicine could also be an option.

Photo: © Jayradhakrishnan/Getty Images